Delivery Order SPE2DB22D2108-SPE2DB25FU5UC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $4,416.12 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Nucynta ER 250 mg tablets (60-count packages) valued at $2,881.48 with firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.15 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count) on August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count units) under a firm fixed-price contract valued at $1,472.04. This non-set-aside award, effective September 3, 2025 with an ultimate completion date of September 4, 2025, represents a single delivery order for pain management pharmaceutical products. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $1,472.04. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion on September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nucynta ER 200 mg tablets (60-count) valued at $2,965.27, with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a $6,441.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units). This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026. The order will be fulfilled from the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,694.17 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order carries no set-aside designation and was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Nucynta ER 250 mg tablets (60-count units) with a contract value of $30,366.81. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5UCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,268.26. This non-competitive delivery order represents a firm fixed-price transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor agreement extending through December 2026. The place of performance is listed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is one of numerous pharmaceutical procurements AmerisourceBergen fulfills through its DLA partnership, which encompasses a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities supporting military and veteran healthcare systems. Nucynta ER, an extended-release pain management pharmaceutical, aligns with the company's demonstrated capabilities in supplying pain management pharmaceuticals alongside its broader offerings in diabetes medications, neurological treatments, antibiotics, and specialty medical supplies. The contract demonstrates AmerisourceBergen's continued role as a critical pharmaceutical distributor within the federal medical supply chain serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/11/25 |